News

PCSK9 inhibitor lowers risk of first heart attack and stroke in high-risk adults

PCSK9 inhibitor lowers risk of first heart attack and stroke in high-risk adults

Credit: Pixabay/CC0 Public Domain Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major adverse cardiovascular events in those who are at high risk. Results were presented today at the American Heart Association Scientific Sessions

Stenting all blocked arteries outperforms culprit-only treatment approach, study shows

Stenting all blocked arteries outperforms culprit-only treatment approach, study shows

Credit: Unsplash/CC0 Public Domain Opening all blocked arteries with stents in patients with a heart attack, known as complete revascularization, reduces the risk of death from cardiovascular causes, death from any cause and future heart attacks compared with opening only the culprit artery causing the heart attack according to a new, large international study led